Details of the Drug

General Information of Drug (ID: DMZV27P)

Drug Name

SXC-2023

Indication

Disease Entry	ICD 11	Status	REF
Trichotillomania	6B25.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cystine/glutamate transporter (SLC7A11)	TTBZMIO	XCT_HUMAN	Activator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03797521) A Study in Patients With Trichotillomania (TTM). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Promentis Pharmaceuticals.